Review Article
Microenvironment and Radiation Therapy
Table 1
Antiangiogenic agents with radiosensitizing potentials.
| Category | Representative strategies/protein/drugs | References |
| Endogenous angiogenesis inhibitor | Angiostatin, | [45–47] | Endostatin | [48–50] |
| Anti-VEGF antibody | Bevacizumab | [36, 40, 52–54] |
| Anti-VEGFR antibody | DC101 | [43, 55] |
| Anti-VEGFR tyrosine kinase inhibitor and multitarget tyrosine kinase inhibitor | Vatalanib (PTK787), | [56, 57] | Vandetanib (ZD6474), | [58, 59] | Cediranib (AZD2171) | [60, 61] | Semaxanib (SU5416), | [62, 63] | SU6668 | [64] | SU11657 | [44] | Sunitinib (SU11248) | [65, 66] |
| Others | TNP-470 | [51, 67, 68] | Thalidomide | [69] |
|
|